INSIGHTS ON DRUG DEVELOPMENT
-
The 5 Ws Of A Human Factors Strategy
A human factors strategy ensures medical products are safe, effective, and compliant by integrating user-focused design early, reducing risks, and optimizing regulatory approval processes.
-
Spray Dried Dispersions In Controlled Release Formulations
Integrating spray dried dispersions with CR strategies addresses poor drug solubility and the need for tailored release kinetics. Explore considerations to ensure stability and sustained supersaturation.
-
Cell Cycle Mapping In Tumors With Advanced Technologies
Discover how spatial profiling and advanced imaging tools are transforming drug discovery, featuring Wayne Stallaert’s lab’s work on cell cycle mapping and biomarker insights in cancer research.
-
Understanding Adeno-Associated Virus Vector Impurities
AAV vectors hold promise for gene therapy, but removing product-related impurities remains a challenge. Learn how cell line development and process optimization are advancing rAAV production.
-
Integrating Phase-Appropriate Quality Standards12/9/2024
Incorporating phase-specific quality standards ensures GMP compliance. Collaborating with an experienced CDMO addresses late-stage quality needs and efficiently manages development timelines.
-
From Model To Molecule: Combining AI And Experimental Strategies To Transform Drug Development3/8/2026
See how integrating AI-driven predictive modeling with well-designed experimental validation can help overcome development challenges, improve decision-making, and support accurate evaluation of API solid-state properties.
-
New And Upcoming Trends In Immunodiagnostics7/15/2024
Explore the latest trends and cutting-edge technologies in immunodiagnostics that are transforming disease detection.
-
Highly Sensitive ELISAs In 90 Minutes9/11/2024
Traditional ELISA methods are often limited by their relatively low throughput and need for multiple wash steps. Learn about a solution that overcomes these challenges and provides rapid results.
-
Are You Keeping Pace With Oligo Synthesis Optimization?11/18/2025
The rapidly expanding oligo market demands optimized RNA synthesis. Examine key innovations and workflow insights to maximize resources and control long-term manufacturing costs.
DRUG DEVELOPMENT SOLUTIONS
-
Discover three solutions that provide the performance, reliability, and ease-of-use required for the most demanding applications in drug discovery, protein-protein interactions, structure-function characterization, and more.
-
Enhance therapeutic success by optimizing N-glycan profiles with titratable formulations tailored to meet your bioproduction needs.
-
Waters series of chromatography columns and standards offer scientists the diverse range of chromatographic selectivities needed to help characterize today's biotherapeutics and biosimilars.
-
Automated bioprinting solution for high-content screening with the BAB400 bioprinter for optimized 3D tissue and organoid workflow.